Beyond TNBC: Repositioning of Clofazimine Against a Broad Range of Wnt-Dependent Cancers
Wnt signaling plays key roles in oncogenic transformation and progression in a number of cancer types, including tumors in the breast, colon, ovaries, liver, and other tissues. Despite this importance, no therapy targeting the Wnt pathway currently exists. We have previously shown that the anti-myco...
Main Authors: | Jiabin Xu, Alexey Koval, Vladimir L. Katanaev |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.602817/full |
Similar Items
-
Clofazimine: A journey of a drug
by: Jiabin Xu, et al.
Published: (2023-11-01) -
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers
by: Kamal Ahmed, et al.
Published: (2016-07-01) -
Wnt-Independent SARS-CoV-2 Infection in Pulmonary Epithelial Cells
by: Alexey Koval, et al.
Published: (2023-08-01) -
Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
by: Cédric Boudou, et al.
Published: (2022-10-01) -
Small Molecule Wnt Pathway Modulators from Natural Sources: History, State of the Art and Perspectives
by: Artem Blagodatski, et al.
Published: (2020-03-01)